Zobrazeno 1 - 10
of 95
pro vyhledávání: '"Anil Kumar Chhillar"'
Publikováno v:
ACS Omega, Vol 7, Iss 36, Pp 32665-32678 (2022)
Externí odkaz:
https://doaj.org/article/42167ccda4f14098913ddd57a8c64bcb
Recent advances in nanotechnology for the improvement of conventional agricultural systems: A review
Publikováno v:
Plant Nano Biology, Vol 4, Iss , Pp 100032- (2023)
Agriculture provides food and raw materials for the construction, energy, textile and pharmaceutical industries. Recently, agriculture is facing several concerns including climate change, soil degradation, decreasing land holding, urbanization, unsus
Externí odkaz:
https://doaj.org/article/6a69814698544666ae291526db886532
Publikováno v:
Sensors International, Vol 1, Iss , Pp 100028- (2020)
Bacteria are unambiguously menacing for community healthiness globally. The common reservoirs of bacteria are contaminated foods, animals, polluted water and soil. There are several diseases causing bacteria such as Vibrio, Listeria, Yersinia, Salmon
Externí odkaz:
https://doaj.org/article/8bfb436c610a449c80c86ee9b2774d38
Autor:
Akanksha, Behl, Nagendra Nath, Das, Krishna Kant, Sharma, Namita, Sharma, Prity, Gulia, Anil Kumar, Chhillar
Publikováno v:
Current Cancer Drug Targets. 23:235-241
Aims: Generation of human anti-MUC1 peptide through neural network training and monomeric design method. Analyzing 9-mer peptide potential computationally for treatment of HER2-positive breast cancer. Background: Extract human MUC1 sequences from var
Autor:
Annu Verma, Ritu Jakhar, Dev Kumar, Vijay Kumar, Twinkle Dhillon, Mehak Dangi, Anil Kumar Chhillar
Publikováno v:
Journal of Biomolecular Structure and Dynamics. :1-21
Autor:
Neelam, Yadav, Twinkle, Dahiya, Anil Kumar, Chhillar, Jogender Singh, Rana, Hari Mohan, Saini
Publikováno v:
Current Pharmaceutical Biotechnology. 23:1556-1568
Cancer is the uncontrolled proliferation of cells that involves accumulation of genetic mutations by different types of mutagens including physical, chemical, and biological. Conse-quently, normal cell cycles get interrupted. Immunological assays, hi
Autor:
Anil Kumar Chhillar, Sudesh Kumari, Prity Gulia, Namita Sharma, Sweety Dahiya, Pooja Choudhary
Publikováno v:
Current Bioactive Compounds. 19
Abstract: To combat the escalating antimicrobial resistance, we need to develop new medications constantly. Recently, scientists more focused on endophytes to search for novel antimicrobial natural products. Endophytes are explored as 'bio-factories'
Autor:
Sweety Dahiya, Aruna Punia, Namita Sharma, Anil Kumar Chhillar, Prity Gulia, Virinder S. Parmar, Pooja Choudhary
Publikováno v:
Current Drug Targets. 23:116-125
Fungal infections have shown an upsurge in recent decades, which is mainly because of the increasing number of immunocompromised patients and the occurrence of invasive candidiasis has been found to be 7-15 fold greater than that of invasive aspergil
Autor:
Samarjeet Siwal, Neeraj K. Saini, Adesh K. Saini, Vijay Kumar Thakur, Anil Kumar Chhillar, Reena V. Saini, Priyanka Thakur
Publikováno v:
BIOCELL. 46:309-324
Publikováno v:
Mini-Reviews in Medicinal Chemistry. 21:2337-2346
Fungi are recognized as key pathogens in immunocompromised patients. The invasive infection always remains a problem for clinicians due to high morbidity and mortality. The treatments of fungal infections are hampered by conventional drugs, which are